Amica Retiree Medical Trust Sells 232 Shares of Accenture plc (NYSE:ACN)

Amica Retiree Medical Trust lessened its holdings in shares of Accenture plc (NYSE:ACN) by 8.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,666 shares of the information technology services provider’s stock after selling 232 shares during the period. Accenture makes up 0.9% of Amica Retiree Medical Trust’s portfolio, making the stock its 27th biggest position. Amica Retiree Medical Trust’s holdings in Accenture were worth $938,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. increased its position in shares of Accenture by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 60,394,657 shares of the information technology services provider’s stock worth $21,246,236,000 after acquiring an additional 392,183 shares in the last quarter. State Street Corp lifted its holdings in shares of Accenture by 1.8% in the third quarter. State Street Corp now owns 27,400,836 shares of the information technology services provider’s stock valued at $9,685,648,000 after purchasing an additional 471,792 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Accenture by 378.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,491,736 shares of the information technology services provider’s stock worth $1,941,219,000 after buying an additional 4,345,039 shares during the period. Charles Schwab Investment Management Inc. raised its position in Accenture by 2.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,964,480 shares of the information technology services provider’s stock valued at $1,746,455,000 after buying an additional 140,726 shares during the last quarter. Finally, Amundi lifted its stake in Accenture by 27.9% in the 4th quarter. Amundi now owns 3,790,069 shares of the information technology services provider’s stock valued at $1,353,909,000 after acquiring an additional 826,038 shares in the last quarter. 75.14% of the stock is currently owned by institutional investors and hedge funds.

Accenture Stock Up 0.8 %

Shares of NYSE ACN opened at $311.38 on Thursday. The company has a market cap of $194.86 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 3.23 and a beta of 1.24. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.17. Accenture plc has a 12 month low of $278.69 and a 12 month high of $398.35. The stock has a 50-day moving average price of $356.77 and a two-hundred day moving average price of $356.56.

Accenture (NYSE:ACN) last issued its quarterly earnings data on Thursday, March 20th. The information technology services provider reported $2.82 EPS for the quarter, beating the consensus estimate of $2.81 by $0.01. The business had revenue of $16.70 billion during the quarter, compared to the consensus estimate of $16.64 billion. Accenture had a net margin of 11.41% and a return on equity of 26.91%. The firm’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.77 EPS. As a group, analysts forecast that Accenture plc will post 12.73 earnings per share for the current fiscal year.

Accenture Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 10th will be issued a $1.48 dividend. The ex-dividend date of this dividend is Thursday, April 10th. This represents a $5.92 dividend on an annualized basis and a yield of 1.90%. Accenture’s dividend payout ratio (DPR) is presently 48.89%.

Insider Buying and Selling

In other Accenture news, CFO Angie Y. Park sold 685 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $354.38, for a total value of $242,750.30. Following the sale, the chief financial officer now owns 8,674 shares in the company, valued at approximately $3,073,892.12. The trade was a 7.32 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Melissa A. Burgum sold 232 shares of the firm’s stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $394.46, for a total value of $91,514.72. Following the transaction, the chief accounting officer now owns 8,915 shares of the company’s stock, valued at $3,516,610.90. This trade represents a 2.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 21,905 shares of company stock worth $8,181,753 in the last ninety days. Company insiders own 0.02% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Wolfe Research upgraded shares of Accenture from a “peer perform” rating to an “outperform” rating and set a $425.00 price objective on the stock in a report on Wednesday, January 8th. Barclays cut their price target on shares of Accenture from $415.00 to $390.00 and set an “overweight” rating on the stock in a research report on Monday. The Goldman Sachs Group upgraded Accenture from a “neutral” rating to a “buy” rating and raised their price target for the company from $370.00 to $420.00 in a research note on Friday, December 6th. StockNews.com lowered shares of Accenture from a “buy” rating to a “hold” rating in a research report on Tuesday, March 11th. Finally, UBS Group lowered their price objective on shares of Accenture from $455.00 to $387.00 and set a “buy” rating on the stock in a research note on Friday, March 21st. Eight equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $378.23.

Accenture Company Profile

Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.